We are live on
!
Find out more
AP
AtonRa Partners Portfolio holdings
AUM
$50.2M
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+14.92%
1 Year Est. Return
+47.76%
3 Year Est. Return
+48.32%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$78.5M
AUM Growth
-$23.3M
(-23%)
Cap. Flow
-$22.9M
Cap. Flow
% of AUM
-29.17%
Top 10 Holdings %
Top 10 Hldgs %
20.72%
Holding
116
New
2
Increased
2
Reduced
109
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
+$476K |
| 2 |
Coherent
COHR
|
+$315K |
| 3 |
Outset Medical
OM
|
+$41.2K |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$30.2K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$1.38M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
+$1.18M |
| 3 |
First Solar
FSLR
|
+$934K |
| 4 |
SolarEdge
SEDG
|
+$906K |
| 5 |
Wolfspeed
WOLF
|
+$803K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 48.97% |
| 2 | Healthcare | 38.08% |
| 3 | Financials | 6.07% |
| 4 | Industrials | 5.49% |
| 5 | Communication Services | 1.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPWR
76
DELISTED
SunPower Corporation Common Stock
SPWR
| $449K | 0.57% |
24,924
-18,788
| -43% | -$385K |
|
77
Rapid7
RPD
$634M
| $436K | 0.56% |
12,839
-2,398
| -16% | -$85.7K |
|
78
Corpay
CPAY
$24.2B
| $433K | 0.55% |
2,357
-444
| -16% | -$81.3K |
|
79
Intellia Therapeutics
NTLA
$1.5B
| $430K | 0.55% |
12,332
-4,552
| -27% | -$216K |
|
80
Global Payments
GPN
$22.1B
| $426K | 0.54% |
4,290
-903
| -17% | -$94.1K |
|
81
10x Genomics
TXG
$5.87B
| $421K | 0.54% |
11,553
-3,125
| -21% | -$102K |
|
|
NARI
82
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $417K | 0.53% |
+6,566
| New | +$476K |
|
83
Lantheus
LNTH
$6.82B
| $407K | 0.52% |
7,992
-1,788
| -18% | -$110K |
|
84
Nurix Therapeutics
NRIX
$2.43B
| $405K | 0.52% |
36,928
-9,987
| -21% | -$120K |
|
85
SentinelOne
S
$6.22B
| $401K | 0.51% |
27,466
-2,905
| -10% | -$53.8K |
|
86
Thermo Fisher Scientific
TMO
$211B
| $400K | 0.51% |
727
-154
| -17% | -$81.6K |
|
87
Abbott
ABT
$180B
| $400K | 0.51% |
3,639
-726
| -17% | -$75.2K |
|
|
CTLT
88
DELISTED
CATALENT, INC.
CTLT
| $399K | 0.51% |
8,875
-3,454
| -28% | -$188K |
|
89
Tandem Diabetes Care
TNDM
$1.17B
| $378K | 0.48% |
8,416
-3,543
| -30% | -$160K |
|
90
Pegasystems
PEGA
$4.41B
| $374K | 0.48% |
21,824
-4,478
| -17% | -$77.4K |
|
91
Varonis Systems
VRNS
$5.25B
| $372K | 0.47% |
15,526
-1,642
| -10% | -$37.5K |
|
92
Guardant Health
GH
$19.5B
| $369K | 0.47% |
13,573
-5,177
| -28% | -$237K |
|
93
Fidelity National Information Services
FIS
$21.5B
| $358K | 0.46% |
5,276
-1,118
| -17% | -$79.4K |
|
94
Affirm
AFRM
$23.5B
| $345K | 0.44% |
35,690
-550
| -2% | -$8.29K |
|
95
Twilio
TWLO
$29.1B
| $341K | 0.43% |
6,965
-1,943
| -22% | -$111K |
|
|
SI
96
DELISTED
Silvergate Capital Corporation
SI
| $339K | 0.43% |
19,457
-992
| -5% | -$39.4K |
|
97
Riot Platforms
RIOT
$8.52B
| $321K | 0.41% |
94,708
-7,043
| -7% | -$36.3K |
|
|
98
Coherent
COHR
$55.2B
| $318K | 0.41% |
+9,067
| New | +$315K |
|
|
TPIC
99
DELISTED
TPI Composites
TPIC
| $318K | 0.41% |
31,356
-23,097
| -42% | -$241K |
|
100
Edwards Lifesciences
EW
$47.6B
| $314K | 0.4% |
4,211
-952
| -18% | -$73.4K |
|
Similar funds
JCI
SC
AOGP
ACJ
UFG
KC
P
AMC
AtonRa Partners's Q4 2022 Portfolio in Review
As of Q4 2022, AtonRa Partners held 116 positions worth $78.5M, down 23% from $102M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
AtonRa Partners withdrew a net $22.9M in Q4 2022, closing 3 positions and reducing 109 holdings. Its most notable exit was Abiomed Inc, an estimated $1.18M position sold in full.
By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 49% a quarter earlier, followed by Healthcare and Financials.
Against the trend, AtonRa Partners opened a new position in Inari Medical, Inc. Common Stock worth $417K.
- AtonRa Partners's largest Q4 2022 buy was Inari Medical, Inc. Common Stock: 6,566 shares worth $417K.
- AtonRa Partners added most to Outset Medical in Q4 2022, an estimated $41.2K increase.
- AtonRa Partners's biggest Q4 2022 reduction was Enphase Energy, cutting an estimated $1.38M.
- AtonRa Partners fully exited Abiomed Inc in Q4 2022, selling an estimated $1.18M.
- AtonRa Partners's ten largest holdings make up 21% of its $78.5M portfolio in Q4 2022.
- AtonRa Partners opened 2 new positions and closed 3 in Q4 2022.
- AtonRa Partners's portfolio value fell 23% quarter-over-quarter to $78.5M.
Based on AtonRa Partners's 13F filing for Q4 2022, filed 2 Feb 2023.